Experience with use of Zostavax® in patients with hematologic malignancy and hematopoietic cell transplant recipients
✍ Scribed by Elliot Naidus; Lloyd Damon; Brian S. Schwartz; Cheryl Breed; Catherine Liu
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 850 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a leading cause of death in patients with leukemia and those who have undergone hematopoietic stem cell transplantation. Laboratory studies have demonstrated that iron is essential for __Aspergillus__ growth and virulence. ## METHODS. In
## Abstract Polyomaviruses KI (KIPyV) and WU (WUPyV) were described recently in children with acute respiratory disease. The pathogenic potential of these human viruses has not been determined completely, but a correlation between immunosuppression and virus reactivation has been suggested. In the
## Abstract Cyclosporine is commonly used as an immunosuppressive agent in both solid organ and bone marrow transplant. While used for graft rejection in organ transplantation, cyclosporine has been used to enable tolerance and for prevention of acute graft‐versus‐host disease in bone marrow transp